Institutional investors purchased a net $2.4 million shares of NLNK during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 56.62% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 1.5 Million shares of NewLink Genetics Corp
DRIEHAUS CAPITAL MANAGEMENT LLC Bought 212.7 Thousand shares of NewLink Genetics Corp
COLUMBUS CIRCLE INVESTORS Bought 208.8 Thousand shares of NewLink Genetics Corp